The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.
Abstract
Ribavirin is effective in combination therapies against chronic hepatitis C virus (HCV) infection, although its direct antiviral properties are unclear. We therefore studied the immune-modulatory effects of ribavirin on hepatitis B virus (HBV)- and HCV-specific immune responses. During a 24 week placebo-controlled ribavirin trial in ten patients with chronic HCV infection, HCV antibodies and alanine aminotransferase (ALT) levels decreased transiently whereas the serum levels of HCV RNA remained stable. Effects of ribavirin on human and murine phytohaemagglutinin (PHA)-activated T cells included inhibition of in vitro proliferation and modulation of IL-2, IL-4, IFN-gamma and TNF-alpha levels. HBcAg- and HBeAg-specific IL-2 and IFN-gamma levels were > or = 25-fold higher in mice immunized with HBV core- or e-antigens (HBcAg, HBeAg) while receiving ribavirin compared to untreated mice, but IL-4 and IL-6 remained constant. Concordantly, a slight shift was observed in the IgG subclass distribution of the humoral responses of ribavirin-treated mice to HBeAg and HCV NS3 protein. Ribavirin treatment of HBeAg-transgenic (HBeAg-Tg) mice induced a dose-dependent down-regulation of T helper (Th)2-mediated antibody production to HBeAg. In ribavirin-treated HBeAg-Tg mice anti-HBe IgG1 (positively regulated by Th2 cytokines) decreased simultaneously as both anti-HBe IgG2a (positively regulated by Th1 cytokines) levels and in vitro T-cell IFN-gamma production increased, indicating a change in the Th1/Th2 balance. Thus, the present data suggest that ribavirin is not strictly an antiviral compound, but rather it alters the T-cell balance in the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
Stevens, T. L., Bossie, A., Sanders, V. M., Fernandez-Botran, R., Coffman, R. L., Mosmann, T. R., & Vitetta, E. S. (1988) · Nature · doi:10.1038/334255a0 · Cited by 933 · cited 2×
“Furthermore, an inverse relationship was found between ribavirin dose and the level of anti-HBe IgG1, an IgG isotype negatively regulated by Th1-derived cytokines (Stevens et al., 1988).”
BackgroundReichard, O., Norkrans, G., Frydén, A., Braconier, J.-H., Sönnerborg, A., & Weiland, O. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06088-1 · Cited by 629
Self-citationIs a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
Milich, D. R., Jones, J. E., Hughes, J. L., Price, J., Raney, A. K., & McLachlan, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6599 · Cited by 580
Self-citationWaris, M. E., Tsou, C., Erdman, D. D., Zaki, S. R., & Anderson, L. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.2852-2860.1996 · Cited by 364
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study
Dusheiko, G. M., Main, J., Thomas, H. C., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80225-x · Cited by 355
Connors, M., Giese, N. A., Kulkarni, A. B., Firestone, C. Y., Morse, H. C., & Murphy, B. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5321-5325.1994 · Cited by 348
Ribavirin as Therapy for Chronic Hepatitis C: A Randomized, Double-Blind, Placebo-Controlled Trial
Di Bisceglie, A. M., Conjeevaram, H. S., Fried, M. W., Sallie, R., Park, Y., Yurdaydin, C., Swain, M., Kleiner, D. E., Mahaney, K., & Hoofnagle, J. H. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-12-199512150-00001 · Cited by 328
Importance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans
Fairbanks, L. D., Bofill, M., Ruckemann, K., & Simmonds, H. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29682 · Cited by 310
Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C
Lai, M., Kao, J., Yang, P., Wang, J., Chen, P., Chan, K., Chu, J., & Chen, D. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8898645 · Cited by 243
Milich, D. R., Schödel, F., Hughes, J. L., Jones, J. E., & Peterson, D. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2192-2201.1997 · Cited by 178
Self-citation
Cited by
Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients
Kamar, N., Izopet, J., Tripon, S., Bismuth, M., Hillaire, S., Dumortier, J., Radenne, S., Coilly, A., Garrigue, V., D'Alteroche, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1215246 · Cited by 520
IMP Dehydrogenase: Structure, Mechanism, and Inhibition
Hedstrom, L. (2009) · Chemical Reviews · doi:10.1021/cr900021w · Cited by 428
Ruzek, D., Avšič Županc, T., Borde, J., Chrdle, A., Eyer, L., Karganova, G., Kholodilov, I., Knap, N., Kozlovskaya, L., Matveev, A., et al. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.01.014 · Cited by 414
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19
Khalili, J. S., Zhu, H., Mak, N. S. A., Yan, Y., & Zhu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25798 · Cited by 359
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
Lau, J. Y. N., Tam, R. C., Liang, J. T., & Hong, Z. (2002) · Hepatology · doi:10.1053/jhep.2002.32672 · Cited by 337
Metadata
- Authors
- Hultgren, C., Weiland, O., Milich, D. R., & S√§llberg, M.
- Venue
- Journal of General Virology
- Publisher
- Microbiology Society
- Published
- 1998-10-01
- Volume
- 79
- Issue
- 10
- Pages
- 2381-2391
- ISSN
- 0022-1317 (ISSN-L)
- 1465-2099
- OpenAlex
- W2135715865
- Cited by
- 279
- References
- 21
- FWCI
- 12.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. https://app.cochat.ai/papers/10.1099/0022-1317-79-10-2381
- The paper
- Hultgren, C., Weiland, O., Milich, D. R., & S√§llberg, M. (1998). The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. Journal of General Virology. https://doi.org/10.1099/0022-1317-79-10-2381
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.